Skip to content
The Policy VaultThe Policy Vault

biologic immunomodulator agentsBlue Cross Blue Shield of Oklahoma

plaque psoriasis (PS)

Initial criteria

  • Has tried and had an inadequate response to ONE conventional agent (acitretin, anthralin, calcipotriene, calcitriol, coal tar products, cyclosporine, methotrexate, pimecrolimus, PUVA, tacrolimus, tazarotene, topical corticosteroids) after at least a 3-month duration OR has intolerance/hypersensitivity
  • FDA labeled contraindication to ALL conventional agents used in PS OR
  • Severe active PS (e.g., >10% BSA, select locations, etc.) OR
  • Concomitant severe psoriatic arthritis OR
  • Medication history indicates use of another biologic immunomodulator agent or Otezla FDA labeled or supported for PS